Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.82 | 47.02 |
| PEG Ratio (TTM) | -0.03 | 0.52 |
| P/S Ratio (TTM) | 4.72 | 17.82 |
| P/B Ratio (TTM) | 6.03 | 15.66 |
| P/FCF Ratio (TTM) | -2.62 | 40.53 |
| Price to 5YR AVG Earnings Ratio | N/A | 73.15 |
| Price to 5YR AVG FCF Ratio | N/A | 98.80 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -86.39% | -2.61% |
| ROE (TTM) | -391.29% | 8.99% |
| Net Profit Margin (TTM) | -161.53% | 4.47% |
| ROIC 5YR AVG | N/A | 5.28% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | -688.38% | N/A |
| Revenue | N/A | 15.23% | N/A |
| Net Income | N/A | -680.77% | N/A |
| Cash Flow | N/A | -5,168.15% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.51 | 1.88 |
| Quick Ratio (TTM) | 1.32 | 1.87 |
| D/E Ratio (TTM) | 0.36 | 0.52 |
| Interest Coverage (TTM) | -41.24 | 12.82 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | N/A | 10.64 |
| LTL to 5YR AVG FCF | N/A | 3.95 |
| Shares Outstanding Growth 5YR AVG | N/A | 51.07% |